1-6 of 6
Ozlem Onder
Close
Sort by
Journal Articles

Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia

Qu Jiang, Johanna Stachelscheid, Johannes Bloehdorn, Alicja Pacholewska, Christoph Aszyk, Francien Grotenhuijs, Tony Müller, Ozlem Onder, Prerana Wagle, Carmen D. Herling, Maria Kleppe, Zhefang Wang, Kevin R. Coombes, Sandra Robrecht, Priya S. Dalvi, Bianca Plosnita, Petra Mayer, Lynne V. Abruzzo, Janine Altmüller, Birgit Gathof, Thorsten Persigehl, Kirsten Fischer, Billy Jebaraj, Hugh Y. Rienhoff, Rupert Ecker, Yue Zhao, Christiane J. Bruns, Stephan Stilgenbauer, Kojo Elenitoba-Johnson, Michael Hallek, Michal R. Schweiger, Margarete Odenthal, Elena Vasyutina, Marco Herling
Journal: Blood
Blood (2023) 142 (1): 44–61.
https://doi.org/10.1182/blood.2022017230
Published: 2023
Includes: Supplemental data
Journal Articles

The NPM1 - TYK2 Chimeric Fusion Promotes Activation of STAT Family Signaling, Skewing Towards Tfh Functional Subset Differentiation and Mature T-Cell Lymphomagenesis

Huang-Chang Liang, Richa Kapoor, Ozlem Onder, Kevin Dennis, Megan S. Lim, Kojo S.J. Elenitoba-Johnson
Journal: Blood
Blood (2022) 140 (Supplement 1): 9281–9282.
https://doi.org/10.1182/blood-2022-169494
Published: 2022
Journal Articles

A Novel FBXO45-Gef-H1 Axis Controls Oncogenic Signaling in B-Cell Lymphoma

Anagh Anant Sahasrabuddhe, Xiaofei Chen, Kaiyu Ma, Rui Wu, Richa Kapoor, Rishi Raj Chhipa, Xiao Zhang, Ozlem Onder, Joel Wilmore, Brian T. Gaudette, Vinodh Pillai, Marilyn M. Li, Joon-Young Ahn, Fuzon Chung, Philippe Szankasi, Venkatesha Basrur, Kevin P Conlon, Nathanael G. Bailey, Cory M Hogaboam, Robert Rottapel, Junhyong Kim, Cristina Lopez, Julian Seufert, Matthias Schlesner, Reiner Siebert, Michael P Cancro, David Allman, Michele Pagano, Louis M. Staudt, Megan S. Lim, Kojo S. J. Elenitoba-Johnson
Journal: Blood
Blood (2021) 138 (Supplement 1): 711.
https://doi.org/10.1182/blood-2021-151245
Published: 2021
Journal Articles

BCL10 Gain-of-Function Mutations Aberrantly Induce Canonical and Non-Canonical NF-Kb Activation and Resistance to Ibrutinib in ABC-DLBCL

Min Xia, Liron David, PhD, Matthew Teater, PhD, Ozlem Onder, PhD MSc, Kojo S. J. Elenitoba-Johnson, MD, Lorena Fontan, PhD, Hao Wu, PhD, Ari Melnick, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-141363
Published: 2020
Journal Articles

Epiproteomic Landscape and Histone Code of Cutaneous T-Cell Lymphoma/Sézary Syndrome

Ozlem Onder, PhD MSc, Rui Wu, MDPhD, Maria Wysocka, PhD, Paul L. Haun, MD, Ellen Kim, MD, Benjamin A Garcia, PhD, David Bahler, MD, Alain Rook, MD, Megan S. Lim, MD,PhD, Kojo S.J. Elenitoba-Johnson, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 780.
https://doi.org/10.1182/blood-2018-99-115347
Published: 2018
Journal Articles

Integrated Phosphoproteomic and N-Glycoproteomic Landscape of Cutaneous T-Cell Lymphoma Reveals Distinctive Pathogenetic Insights and Therapeutic Vulnerabilities

John Simon Van Arnam, MD MS, Delphine C. M. Rolland, PharmD, PhD, Kojo S. J. Elenitoba-Johnson, MD, Megan S. Lim, MDPhD, Özlem Önder, PhD, Nathanael G. Bailey, MD, David Bahler, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2763.
https://doi.org/10.1182/blood.V130.Suppl_1.2763.2763
Published: 2017